This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Pharmacyclics, Inc.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Cassandra Shu: Innovator in Pharmaceutical Formulations
Introduction
Cassandra Shu is a notable inventor based in Belmont, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for various diseases.
Latest Patents
Cassandra Shu holds a patent for "Formulations of a Bruton's Tyrosine Kinase Inhibitor." This patent describes a specific Bruton's tyrosine kinase (Btk) inhibitor, identified as 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one. The patent includes novel pharmaceutical formulations and compositions that incorporate the Btk inhibitor. Additionally, it outlines methods for using the Btk inhibitor, either alone or in combination with other therapeutic agents, to treat autoimmune diseases, heteroimmune diseases, cancer (including lymphoma), and inflammatory conditions.
Career Highlights
Cassandra Shu is currently employed at Pharmacyclics, Inc., where she continues to advance her research and development efforts. Her work focuses on creating effective pharmaceutical solutions that address critical health challenges.
Collaborations
Cassandra collaborates with talented professionals in her field, including Alexander Jacob McVey and Ching Wah Chong. These partnerships enhance her research and contribute to the innovative environment at Pharmacyclics, Inc.
Conclusion
Cassandra Shu is a pioneering inventor whose work in pharmaceutical formulations is making a significant impact on the treatment of various diseases. Her contributions are vital to advancing medical science and improving patient outcomes.